ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2016
[Expression of LncRNA AK09398 and Relationship with Prognosis in Patients with Small Cell Lung Cancer].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.Frontiers in oncology · 2023Review
- Prognostic value of lncRNAs in lung carcinoma: a meta-analysis.Oncotarget · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmall cell lung cancer (SCLC) accounts for approximately 15% of lung cancer. The poor prognosis of SCLC patients is attributed to the early blood and lymph node metastasis. However, the mechanism of SCLC is still unclear. Recent studies show that LncRNA plays an important role in the development, metastasis, and apoptosis of tumor. Thus, the present study aimed to investigate the expression and clinical significance of LncRNA AK09398 in SCLC.
methodsQuantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect the expression of LncRNA AK09398 in 118 cases of SCLC and non-cancerous tissues. qRT-PCR was also utilized to analyze the relationship between the expression and clinical pathological characteristics and prognosis of SCLC.
resultsThe expression of LncRNA AK09398 in lung cancer tissues was (7.813±0.373). This value was significantly increased in paracarcinoma tissues (1.782±0.116) and normal lung tissues (1.209±0.200). The difference was statistically significant (F=58.41, P<0.001). AK09398 expression was positively correlated with disease stage, lymph node and distant metastasis, chemosensitivity, and survival status (P<0.05). However, AK09398 expression was not associated with gender and age (P>0.05). Kaplan-Meier analysis demonstrated that high expression level of AK09398 contributed to poor overall survival (P<0.001) and progression-free survival (P<0.001). The multivariate survival analysis also indicated that AK09398 expression, disease stage, and distant metastasis could be independent prognostic markers.
conclusionsLncRNA AK09398 is involved in the development of SCLC and can be used as a molecular marker to evaluate the prognosis of SCLC. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.